Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity. [electronic resource] by
- Walker, Daniel P
- Zawistoski, Michael P
- McGlynn, Molly A
- Li, Jian-Cheng
- Kung, Daniel W
- Bonnette, Peter C
- Baumann, Amy
- Buckbinder, Leonard
- Houser, Janet A
- Boer, Jason
- Mistry, Anil
- Han, Seungil
- Xing, Li
- Guzman-Perez, Angel
Producer: 20090821
In:
Bioorganic & medicinal chemistry letters vol. 19
Availability: No items available.
|
|
6.
|
Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis. [electronic resource] by
- Buckbinder, Leonard
- Crawford, David T
- Qi, Hong
- Ke, Hua Zhu
- Olson, Lisa M
- Long, Kelly R
- Bonnette, Peter C
- Baumann, Amy P
- Hambor, John E
- Grasser, William A
- Pan, Lydia C
- Owen, Thomas A
- Luzzio, Michael J
- Hulford, Catherine A
- Gebhard, David F
- Paralkar, Vishwas M
- Simmons, Hollis A
- Kath, John C
- Roberts, W Gregory
- Smock, Steven L
- Guzman-Perez, Angel
- Brown, Thomas A
- Li, Mei
Producer: 20070815
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 104
Availability: No items available.
|